Zacks: Analysts Anticipate Cooper Companies Inc (COO) to Post $2.97 Earnings Per Share
Wall Street analysts expect Cooper Companies Inc (NYSE:COO) to announce $2.97 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Ten analysts have issued estimates for Cooper Companies’ earnings, with the lowest EPS estimate coming in at $2.92 and the highest estimate coming in at $3.11. Cooper Companies posted earnings per share of $2.65 during the same quarter last year, which indicates a positive year over year growth rate of 12.1%. The firm is expected to issue its next earnings results on Thursday, December 6th.
On average, analysts expect that Cooper Companies will report full year earnings of $11.62 per share for the current year, with EPS estimates ranging from $11.56 to $11.79. For the next financial year, analysts anticipate that the company will post earnings of $12.25 per share, with EPS estimates ranging from $12.02 to $12.75. Zacks Investment Research’s earnings per share averages are an average based on a survey of research firms that cover Cooper Companies.
Cooper Companies (NYSE:COO) last posted its earnings results on Thursday, August 30th. The medical device company reported $3.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.07 by ($0.07). The company had revenue of $660.00 million during the quarter, compared to analysts’ expectations of $653.44 million. Cooper Companies had a net margin of 5.23% and a return on equity of 17.53%.
NYSE COO traded up $5.10 during trading on Tuesday, hitting $264.76. The company’s stock had a trading volume of 267,300 shares, compared to its average volume of 424,077. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.54 and a current ratio of 2.58. The company has a market cap of $12.92 billion, a PE ratio of 26.91, a P/E/G ratio of 2.10 and a beta of 0.67. Cooper Companies has a fifty-two week low of $216.47 and a fifty-two week high of $267.98.
In related news, Director Allan E. Rubenstein sold 1,500 shares of Cooper Companies stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $265.37, for a total transaction of $398,055.00. Following the completion of the sale, the director now owns 3,068 shares of the company’s stock, valued at $814,155.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Daniel G. Mcbride sold 10,310 shares of Cooper Companies stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $264.44, for a total value of $2,726,376.40. Following the sale, the chief operating officer now directly owns 38,705 shares of the company’s stock, valued at approximately $10,235,150.20. The disclosure for this sale can be found here. Insiders have sold 81,005 shares of company stock valued at $20,492,936 in the last ninety days. Corporate insiders own 1.60% of the company’s stock.
Several institutional investors have recently added to or reduced their stakes in the stock. Signaturefd LLC purchased a new position in Cooper Companies during the first quarter valued at approximately $144,000. Archford Capital Strategies LLC purchased a new position in Cooper Companies during the first quarter valued at approximately $156,000. First Allied Advisory Services Inc. purchased a new position in Cooper Companies during the first quarter valued at approximately $200,000. GWM Advisors LLC purchased a new position in Cooper Companies during the second quarter valued at approximately $200,000. Finally, IFM Investors Pty Ltd purchased a new position in Cooper Companies during the first quarter valued at approximately $208,000. 97.06% of the stock is owned by hedge funds and other institutional investors.
About Cooper Companies
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Recommended Story: Average Daily Trade Volume – ADTV
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.